METABOLIC SYNDROME AND THE RISK OF ACUTE KIDNEY DAMAGE DEVELOPMENT AFTER CORONARY ARTERY BYPASS PROCEDURE
https://doi.org/10.15829/1560-4071-2015-9-44-50
Abstract
Aim. To find out the causal relationship of metabolic syndrome (MS) with acute kidney damage (AKD) in coronary bypass grafting patients (CABG).
Material and methods. To the clinical comparative study totally 742 patients included (489 men и 253 women) at the age 53 to 67 y. o. (mean 62,1±4,7), who underwent CABG on-pump. Of those 477 (64,3%) did not have the metabolic criteria for MS (1st group), and 265 pts. (35,7%) had MS (2nd group). Depending on the maximum increase of serum creatinine (sCr) during early post-operation period ARF was diagnosed in the 1st group on 119 patients (24,9%) in the 2nd — 92 patients (34,7%). AKD was diagnosed by AKIN.
Results. It was shown that early post operational cardiovascular complications significantly more frequently developed in AKD in both groups, and in the 2nd group comparing to the 1st. Also the procedures of hemodialysis in acute renal failure (3 stage of AKD) in the 1st group performed in 5,9% cases and in the 2nd — in 17,4% cases (p=0,015). In-hospital mortality was 2,0% to 16,3% depending on the development of AKD and MS. However in the 2nd group, in the development AKD as without this, intra-hospital mortality was significantly higher (p<0,05), than in the 1st group. It was revealed that in the case of AKD the parameters of MS were significantly higher than in its absence, especially in the 1st group. Also in the 2nd group, not related to the development of AKD metabolic parameters were higher in the 2nd group than in the 1st. Also, 1st stage and transient AKD were more prevalent in the 1st group, and III stage and non-reversible AKD with the onset of CKD — in the 2nd group. The time of hospitalization in the 2nd group was significantly longer than in the 1st (p=0,008).
Conclusion. It is shown that in MS patients after CABG, comparing to those without MS, the prevalence of AKD is higher 1,5 times, in-hospital mortality — 2,5 times.
About the Authors
B. G. Iskenderov
Penza Institute of Physicians Improvement
Russian Federation
Russian Federation
O. N. Sisina
Penza Institute of Physicians Improvement
Russian Federation
Russian Federation
References
1. National recommendations on diagnostics and treatment of a metabolic syndrome. AllRussian scientific organization of cardiologists. Second revision. Cardiovascular Therapy and Prevention 2009; 8(6). Supplement 2. Russian (Национальные рекомендации по диагностике и лечению метаболического синдрома. Всероссийское научное общество кардиологов. Второй пересмотр. Кардиоваскулярная терапия и профилактика 2009; 8 (6), Приложение 2).
2. Kajimoto K, Miyauchi K, Kasai T, et al. Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009; 137(3): 658-63.
3. Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014; 7: 421-35.
4. Hall ME, do Carmo JM, da Silva AA, et al. Obesity, hypertension and chronic kidney disease. Int J Nephrol and Renovasc Dis 2014; 7: 75-88.
5. van Straten AHM, Bramer S, Soliman Hamad MA, et al. Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg 2010; 89(1): 30-7.
6. Engel AM, McDonough S, Smith JM. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 2009; 88(6): 1793-800.
7. Park SH, Shin WY, Lee EY, et al. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circulation 2011; 75(3): 692–7.
8. Iskenderov BG, Sisina ON. Risk factors and outcomes of acute kidney injure in patients with intact renal function underwent coronary artery bypass grafting. Nefrologiya 2013; 3: 63–7. Russian (Искендеров Б. Г., Сисина О. Н. Факторы риска и исходы острого повреждения почек у пациентов с сохранной функцией почек, подвергнутых аортокоронарному шунтированию. Нефрология 2013; 3: 63–7).
9. Orii K, Hioki M, Iedokoro Y, et al. Prognostic factors affecting clinical outcomes after coronary artery bypass surgery: analysis of patients with chronic kidney disease after 5.9 years of follow-up. J Nippon Med Sch 2011; 78 (3): 156–65.
10. Bagshaw SM, Cruz DN, Aspromonte N, et al. Epidemiology of cardiorenal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010; 25: 1777-784.
11. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between chronic kidney disease and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401.
12. Charytan DM, Yang SS, McGurk S, et al. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. Nephrol Dial Transplant 2010; 25: 3654-63.
13. Angeloni E, Melina G, Benedetto U, et al. Metabolic syndrome affects midterm outcome after coronary artery bypass grafting. Ann Thorac Surg 2012; 93(2): 537-44.
14. Rahmanian PB, Adams DH, Castillo JG, et al. Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both. Am J Cardiol. 2007; 100(11): 1702-8.
15. Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005; 112 (Suppl. 9): 1270-5.
16. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased longterm mortality after cardiothoracic surgery. Circulation 2009; 119: 2444-53.
17. Coca SG, Jammalamadaka D, Sint K, et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2012; 143: 495502.
18. Smirnov AV, Kayukov IG, Degtereva OA, et al. Problems of diagnostics and stratification of burden of acute kidney injury. Nefrologiya 2009; 13(3): 9-18. Russian (Смирнов А. В., Каюков И. Г., Дегтярева О. А. и др. Проблемы диагностики и стратификации тяжести острого повреждения почек. Нефрология 2009; 3: 9-18).
19. Foussas SG, Tsiaousis GZ. Coronary revascularization in patients with chronic renal disease. Hellenic J Cardiol 2007; 48: 218-27.
20. Ejaz AA, Dass B, Lingegowda V, et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urology and Nephrology 2013; 45(2): 449-58.
Review
For citations:
Iskenderov B.G., Sisina O.N. METABOLIC SYNDROME AND THE RISK OF ACUTE KIDNEY DAMAGE DEVELOPMENT AFTER CORONARY ARTERY BYPASS PROCEDURE. Russian Journal of Cardiology. 2015;(9):44-50. (In Russ.) https://doi.org/10.15829/1560-4071-2015-9-44-50
Views:
686
Email this article 